Laparoscopic Ablation Market 2024-2028: Size and Reuse and reprocessing of devices; growth driven by the Application, Some of key Companies Positioned Strategically
The laparoscopic ablation market size by Application (Cancer, Cardiovascular procedures, Urological procedures, Gynecological procedures, and Others), Technique (Radiofrequency ablation, Microwave ablation, Cryoablation, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 1210.1 million. The market is expected to grow at a CAGR of 10.03% between 2024 and 2028.
- In the healthcare industry, reusable medical devices, such as laparoscopic ablation catheters, play a significant role in cost savings for medical centers. However, these devices can accumulate biological debris and microorganisms, leading to healthcare-associated infections (HAIs). To mitigate infection risks and ensure patient compliance, reprocessing is an essential step. This involves rigorous procedures, including cleaning, disassembling, disinfecting, reassembling, inspection, function testing, re-packing, sterilization, and relabeling. Reprocessing can occur on-site or through third-party facilities, ensuring the safe and effective reuse of these devices.
- The Laparoscopic Ablation Market represents a significant business opportunity for key players, driven by the increasing prevalence of various gastrointestinal and liver diseases. This market is characterized by advanced technologies, such as radiofrequency ablation and microwave ablation, offering minimally invasive procedures with faster recovery times and improved patient outcomes. Growing healthcare expenditures, coupled with rising demand for cost-effective and efficient treatments, are further fueling market expansion.
Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:
- AngioDynamics Inc.
- Balmer Medical SA
- Bioventus LLC
- Boston Scientific Corp.
- Conmed Corp.
- EDAP TMS
- HealthTronics Inc.
- Integra Lifesciences Corp.
- Johnson and Johnson Services Inc.
- Medtronic Plc
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/